MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against <i>Staphylococcus aureus</i>
To explore whether combined treatments with daptomycin and gentamicin can prevent the development of <i>Staphylococcus aureus</i> resistance, and whether the possible restriction is associated with changes in antibiotic mutant prevention concentrations (MPCs), the enrichment of daptomyci...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_8cde7af0099b4a75a84e1c1012db1140 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Maria V. Golikova |e author |
700 | 1 | 0 | |a Elena N. Strukova |e author |
700 | 1 | 0 | |a Yury A. Portnoy |e author |
700 | 1 | 0 | |a Stephen H. Zinner |e author |
700 | 1 | 0 | |a Alexander A. Firsov |e author |
245 | 0 | 0 | |a MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against <i>Staphylococcus aureus</i> |
260 | |b MDPI AG, |c 2021-09-01T00:00:00Z. | ||
500 | |a 10.3390/antibiotics10101148 | ||
500 | |a 2079-6382 | ||
520 | |a To explore whether combined treatments with daptomycin and gentamicin can prevent the development of <i>Staphylococcus aureus</i> resistance, and whether the possible restriction is associated with changes in antibiotic mutant prevention concentrations (MPCs), the enrichment of daptomycin- and gentamicin-resistant mutants was studied by simulating 5-day single and combined treatments in an in vitro dynamic model. The MPCs of the antibiotics in the combination were determined at concentration ratios equal to the ratios of 24 h areas, under the concentration-time curve (AUCs) of the antibiotics, as simulated in pharmacodynamic experiments. The MPCs of both daptomycin and gentamicin decreased in the presence of each other; this led to an increase in the time when antibiotic concentrations were above the MPC (<i>T</i><sub>>MPC</sub>). The increases in <i>T</i><sub>>MPC</sub>s were concurrent with increases of the anti-mutant effects of the combined antibiotics. When anti-mutant effects of the antibiotics in single and combined treatments were plotted against the <i>T</i><sub>>MPC</sub>s, significant sigmoid relationships were obtained. These findings suggest that (1) daptomycin-gentamicin combinations prevent the development of <i>S. aureus</i> resistance to each antibiotic; (2) the anti-mutant effects of antibiotic combinations can be predicted using MPCs determined at pharmacokinetic-based antibiotic concentration ratios; (3) <i>T</i><sub>>MPC</sub> is a reliable predictor of the anti-mutant efficacy of antibiotic combinations. | ||
546 | |a EN | ||
690 | |a daptomycin-gentamicin combination | ||
690 | |a in vitro model | ||
690 | |a anti-mutant effect | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antibiotics, Vol 10, Iss 10, p 1148 (2021) | |
787 | 0 | |n https://www.mdpi.com/2079-6382/10/10/1148 | |
787 | 0 | |n https://doaj.org/toc/2079-6382 | |
856 | 4 | 1 | |u https://doaj.org/article/8cde7af0099b4a75a84e1c1012db1140 |z Connect to this object online. |